Press release
Angiotensin Receptor Blockers (ARBs) Market Anticipated To Witness Robust Growth, Surpassing $10.76 Billion By 2029
Angiotensin Receptor Blockers (ARBs)
What Is the Current Angiotensin Receptor Blockers (ARBs) Market Size and Its Estimated Growth Rate?
There has been a consistent increase in the angiotensin receptor blockers (ARBs) market size over the past few years. The market, which was at $8.51 billion in 2024, is anticipated to escalate to $8.87 billion in 2025, showcasing a compound annual growth rate (CAGR) of 4.1%. This upward trajectory during the historical period is due to factors such as the surge in hypertension cases, proven clinical benefits, cardiovascular disease prevalence, protection against kidney diseases, defined clinical guidelines, the adoption of ARBs as the initial treatment approach, along with their cost-effectiveness.
The market size of angiotensin receptor blockers (ARBs) is anticipated to experience consistent expansion in the upcoming years, predicting to soar to $10.76 billion by 2029, with a compound annual growth rate (CAGR) of approximately 5.0%. Factors contributing to this growth during the projected span include methodologies of precision medicine, emphasis on combination therapies, global market growth, treatment strategies based on biomarkers, governmental initiatives, and heightened hypertension awareness. Further future trends include the embracing of telemedicine, investments in research and development, competition from generics and expiring patents, digital health aids for medication compliance, and competition from biosimilar compounds.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8943
How Are Emerging Segments Shaping the Angiotensin Receptor Blockers (ARBs) Market Landscape?
The angiotensin receptor blockers (ARBs) market covered in this report is segmented -
1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Valsartan: Tablets, Capsules, Injectable Forms
2) By Telmisartan: Tablets, Capsules
3) By Losartan: Tablets, Oral Solution
4) By Irbesartan: Tablets, Oral Solution
5) By Azilsartan: Tablets
6) By Olmesartan: Tablets, Oral Suspension
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8943&type=smp
Which Growth Factors Are Influencing Angiotensin Receptor Blockers (ARBs) Market Expansion?
The upward trend in cardiovascular disease prevalence is predicted to stimulate the expansion of the angiotensin receptor blockers market. Cardiovascular disease (CVD), a condition that impacts the heart and blood vessels, typically leads to the formation of fatty residues within the arteries (atherosclerosis) and a heightened probability of blood clots. By assisting in the relaxation of veins and arteries, angiotensin receptor blockers can decrease blood pressure and enhance the heart's ability to pump blood, thereby reducing the odds of cardiovascular disease. For example, in August 2022, the American College of Cardiology, a professional medical organization based in the US, predicted significant increases in cardiovascular risk factors and disease rates in the United States by 2060. Thus, the rising prevalence of cardiovascular diseases is fueling growth in the angiotensin receptor blockers market.
Who Are the Dominant Players Across Different Angiotensin Receptor Blockers (ARBs) Market Segments?
Major companies operating in the angiotensin receptor blockers (ARBs) market include Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma
What Are the Latest Developing Trends in the Angiotensin Receptor Blockers (ARBs) Market?
Top corporations operating in the angiotensin receptor blocker market are creating innovative products such as angiotensin receptor neprilysin inhibitors, aimed at boosting healthcare solutions and enhancing outcomes for cardiovascular patients. These inhibitors, known as ARNIs, are a group of drugs utilized in managing heart failure. Notably, in January 2023, Glenmark Pharmaceuticals, a business based in India, introduced sacubitril and valsartan tablets. These tablets are designed to treat heart failure, specifically aiming at heart failure with a reduced ejection fraction (HFrEF). These tablets are included in the ARNI (angiotensin receptor neprilysin inhibitors) medication class. Sacubitril boosts the natriuretic peptide (NP) system, which helps manage fluid overload and encourages blood vessel expansion, whereas valsartan impedes the renin-angiotensin system (RAS) to reduce blood pressure and lighten the heart's duty. Collectively, they effectively overcome heart failure symptoms, lower the danger of cardiovascular death, and diminish the probability of hospital admittance due to heart failure. Furthermore, these drugs are traded under the Sacu V brand.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/angiotensin-receptor-blockers-arbs-global-market-report
Which Geographic Regions Are Expected to Dominate the Angiotensin Receptor Blockers (ARBs) Market in the Coming Years?
North America was the largest region in the angiotensin receptor blockers (ARBs) market share in 2024. The regions covered in the angiotensin receptor blockers (ARBs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Angiotensin Receptor Blockers (ARBs) Market?
2. What is the CAGR expected in the Angiotensin Receptor Blockers (ARBs) Market?
3. What Are the Key Innovations Transforming the Angiotensin Receptor Blockers (ARBs) Industry?
4. Which Region Is Leading the Angiotensin Receptor Blockers (ARBs) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angiotensin Receptor Blockers (ARBs) Market Anticipated To Witness Robust Growth, Surpassing $10.76 Billion By 2029 here
News-ID: 3976900 • Views: …
More Releases from The Business Research Company
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: A Key Driver P …
The Denosumab Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Denosumab Market Size and Its Estimated Growth Rate?
The market size of denosumab has seen a fast-paced expansion in the past few years. It is projected to surge from $3.27 billion in…
Defense Tactical Radio Market Report 2025-2034: Industry Overview, Trends, And F …
The Defense Tactical Radio Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Defense Tactical Radio Market Size and Its Estimated Growth Rate?
In recent times, the defense tactical radio market size has experienced a swift expansion. This market is projected to increase…
DDoS Protection And Mitigation Security Market Anticipated To Witness Robust Gro …
The DDoS Protection And Mitigation Security Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current DDoS Protection And Mitigation Security Market Size and Its Estimated Growth Rate?
The market for DDoS protection and mitigation security has seen substantial growth in recent years. Its…
The Significance Of Data Volume In Driving The Data Wrangling Market: A Key Driv …
The Data Wrangling Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Data Wrangling Market Size and Its Estimated Growth Rate?
The market size of data wrangling has experienced a quick surge over the past few years. It is projected to increase from…
More Releases for ARBs
Angiotensin II Receptor Blocker (ARBs) API Market Is Likely to Experience a Trem …
Current and upcoming market and organization scenario is studied in this Angiotensin II Receptor Blocker (ARBs) API market research report. It aims at covering business overviews, market dynamics including drivers, constraints and market development potential factors. Customer purchasing habits, competitors' future actions, barriers and key developments are all covered in this market research report. It becomes easy to attain huge insights into entire market condition and industry growth for the…
Angiotensin II Receptor Blocker (ARBs) API Market Scope, Future Prospects And Co …
This comprehensive Angiotensin II Receptor Blocker (ARBs) API market report provides an overview of market characteristics including drivers and constraints, as well as current trends and major price structure. For the forecast period 2021-2027, it also does market scenario assessment and competitive analysis. The strategic framework and emerging opportunities presented here assist company actors in making smart decisions and propelling firm success. This useful market report aids in obtaining…
Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report…
Angiotensin II Receptor Blocker (ARBs) API Market To Upscale Amidst Technologica …
The professional intelligence report presents a comprehensive evaluation of various factors that may influence the future performance of the Global Angiotensin II Receptor Blocker (ARBs) API Market during the forecast period of 2021 to 2027. It highlights a host of interlinked factors that may create promising growth opportunities in the global Angiotensin II Receptor Blocker (ARBs) API market in coming years. It also provides holistic perspective regarding different trends that…
Angiotensin II Receptor Blocker (ARBs) API Market 2021 Industry Analysis, Segmen …
The Angiotensin II Receptor Blocker (ARBs) API Market research report added by MarketInsightsReports is an in-depth analysis of the latest trends, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market introduction, Angiotensin II Receptor Blocker (ARBs) API market definition, regional market scope, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect elements analysis,…
Angiotensin Receptor Blockers (ARBs) Market: Key Players, Trends, Drivers, Chall …
The study of Angiotensin Receptor Blockers (ARBs) Market published by Prophecy Market Insights offerings all compilation of the historical, current and future outlook of the market. This report is very helpful for understanding the market complexity. This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue…
